CVRx is a medical technology company focused on therapies that support people living with heart failure. Its featured product, Barostim, is an implantable neuromodulation device designed to help relieve heart failure symptoms. The therapy works by stimulating baroreceptors, natural sensors that help the nervous system regulate heart, kidney, and vascular function. This stimulation may reduce the heart’s workload and help it pump more efficiently. CVRx describes Barostim as distinct from a pacemaker or defibrillator.

The company shares information for patients and healthcare professionals, including guidance on getting Barostim, explanations of how the therapy works, patient stories, frequently asked questions, clinical results, and important safety and regulatory information. The website reports that clinical studies found improvements in exercise capacity, quality of life, and functional status among patients receiving the therapy, while noting that outcomes vary. CVRx also provides information about its work in hypertension, alongside company resources for investors, careers, and contact inquiries.